Literature DB >> 1380483

Mapping the human acetylcholinesterase gene to chromosome 7q22 by fluorescent in situ hybridization coupled with selective PCR amplification from a somatic hybrid cell panel and chromosome-sorted DNA libraries.

G Ehrlich1, E Viegas-Pequignot, D Ginzberg, L Sindel, H Soreq, H Zakut.   

Abstract

To establish the chromosomal location of the human ACHE gene encoding the acetylcholine hydrolyzing enzyme acetylcholinesterase (ACHE, acetylcholine acetylhydrolase, E.C. 3.1.1.7), a human-specific polymerase chain reaction (PCR) procedure that supports the selective amplification of ACHE DNA fragments from human genomic DNA was employed with 19 human-hamster somatic cell hybrids carrying one or more human chromosomes. Informative ACHE-specific PCR fragments were produced from two cell lines, both of which include human chromosome 7, but not with DNA from 17 cell hybrids carrying various combinations of all human chromosomes other than 7. Fluorescent in situ hybridization of biotinylated ACHE DNA with metaphase chromosomes from human peripheral blood lymphocytes revealed prominent labeling on the 7q22 position. Therefore, further tests were performed to confirm the chromosome 7 location. DNA samples from the two cell lines including chromosome 7 and the ACHE gene were positive with PCR primers informative for the human cystic fibrosis CFTR gene, known to reside at the 7q31.1 position, but negative for the ACHE-related butyrylcholinesterase (BCHE, acylcholine acylhydrolase, E.C. 3.1.1.8) gene, mapped at the 3q26-ter position, confirming that these lines contain chromosome 7 but not chromosome 3. In contrast, three other cell lines including chromosome 3, but not 7, were BCHE-positive and ACHE-negative. In addition, genomic DNA from a sorted chromosome 7 library supported the production of ACHE- but not BCHE-specific PCR products, whereas with DNA from a sorted chromosome 3 library, the BCHE but not the ACHE fragment was amplified.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380483     DOI: 10.1016/0888-7543(92)90037-s

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  8 in total

Review 1.  Natural inhibitors of cholinesterases: implications for adverse drug reactions.

Authors:  M D Krasowski; D S McGehee; J Moss
Journal:  Can J Anaesth       Date:  1997-05       Impact factor: 5.063

2.  Expression of a human acetylcholinesterase promoter-reporter construct in developing neuromuscular junctions of Xenopus embryos.

Authors:  R Ben Aziz-Aloya; S Seidman; R Timberg; M Sternfeld; H Zakut; H Soreq
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

3.  Antisense oligonucleotide inhibition of acetylcholinesterase gene expression induces progenitor cell expansion and suppresses hematopoietic apoptosis ex vivo.

Authors:  H Soreq; D Patinkin; E Lev-Lehman; M Grifman; D Ginzberg; F Eckstein; H Zakut
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

Review 4.  Fine mapping of the autosomal dominant split hand/split foot locus on chromosome 7, band q21.3-q22.1.

Authors:  S W Scherer; P Poorkaj; T Allen; J Kim; D Geshuri; M Nunes; S Soder; K Stephens; R A Pagon; M A Patton
Journal:  Am J Hum Genet       Date:  1994-07       Impact factor: 11.025

5.  Patients with congenital myasthenia associated with end-plate acetylcholinesterase deficiency show normal sequence, mRNA splicing, and assembly of catalytic subunits.

Authors:  S Camp; S Bon; Y Li; D K Getman; A G Engel; J Massoulié; P Taylor
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

6.  Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic).

Authors:  C Donger; E Krejci; A P Serradell; B Eymard; S Bon; S Nicole; D Chateau; F Gary; M Fardeau; J Massoulié; P Guicheney
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

7.  Acetylcholinesterase involvement in apoptosis.

Authors:  Xue-Jun Zhang; David S Greenberg
Journal:  Front Mol Neurosci       Date:  2012-04-10       Impact factor: 5.639

8.  Novel 2-pheynlbenzofuran derivatives as selective butyrylcholinesterase inhibitors for Alzheimer's disease.

Authors:  Amit Kumar; Francesca Pintus; Amalia Di Petrillo; Rosaria Medda; Paola Caria; Maria João Matos; Dolores Viña; Enrico Pieroni; Francesco Delogu; Benedetta Era; Giovanna L Delogu; Antonella Fais
Journal:  Sci Rep       Date:  2018-03-13       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.